Assignee
NESS THERAPEUTICS INC
US·0 granted patents·2 pending applications·0 citations·filing 2023–2023
Top patents by PatentIndex Score
2 records- 0154US2024262801A1Compounds having 5-(2-fluoro-6-hydroxyphenyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide as inhibitors of protein kinase phosphatase enzymesNESS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0254US2025313554A1Ptpn2 inhibitorsNESS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NESS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →